Orbimed Advisors LLC Adicet Bio, Inc. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 11,447,140 shares of ACET stock, worth $8.01 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
11,447,140
Previous 11,447,140
-0.0%
Holding current value
$8.01 Million
Previous $11 Million
20.84%
% of portfolio
0.27%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding ACET
# of Institutions
63Shares Held
57.5MCall Options Held
36.9KPut Options Held
16.5K-
Tang Capital Management LLC San Diego, CA8.22MShares$5.76 Million0.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.28 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.82MShares$2.67 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.24 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC2.95MShares$2.06 Million2.78% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $28M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...